main banner
You are here: Home page » Resources » Press releases

HEAL responds to Berlaymont Declaration on endocrine disruptors


HEAL responds to Berlaymont Declaration on endocrine disruptors

Brussels, 24 May 2013 – A group of the world’s leading scientific experts on endocrine disrupting chemicals have made the strongest ever call for regulatory action on endocrine disrupting chemicals with the launch of the Berlaymont Declaration. (1)

The Declaration makes an urgent plea to the European Commission “to implement regulatory measures that are in line with the best available science”. It says that “scientific uncertainty should not delay regulatory action and commercial interests must not take precedent over concerns about risks associated with endocrine disruptors”.

The signatories to “The 2013 Berlaymont Declaration on Endocrine Disrupters” point to alarming signs of a growing public health burden in Europe. They say that: “the prevalence of endocrine-related diseases is higher than it has ever been and that this disease burden continues to increase in the EU and globally.”

The scientists express their concern that: Breast cancer is rising rapidly in Eastern and Southern European EU countries and that in Western Europe although the increases are slower or leveling off, the rates are much higher than 30 years ago; Large proportions of young men have semen quality that is so poor that it will seriously affect their changes of siring children; and obesity, diabetes and metabolic syndrome have increased dramatically in almost all EU member states.

Lisette van Vliet, Senior Policy Adviser, Health and Environment Alliance (HEAL) said:

“The Declaration is the latest and perhaps most pointed expression that scientific experts have made for urgent and comprehensive regulatory action. It is explicit about the need for a regulatory regime that classifies endocrine disruptors in a scientifically sound manner. It is also categorical about the need to update the testing requirements of various laws, without which it says our ED regulation will fail. How much louder and clearer do our top scientists have to be before the EU acts to protect public health? We hope the EU Commissioners fully take these points on board in their upcoming decisions on the EU Strategy for endocrine disruptors and on Criteria to identify them, as well as in the review of how the REACH law treats endocrine disruptors.”


Lisette van Vliet, Senior Policy Adviser, Health and Environment Alliance (HEAL), Tel: +32 2 234 36 45. Mob: +32 484 614 528, Email:


1. The 2013 Berlaymont Declaration on Endocrine, officially launched on 24 May 2013 is signed in a personal capacity by 89 scientists, including Prof Ake Bergman, Stockholm University; Prof Susan Jobling, Brunel University, UK; Prof Karen A Kidd, University of New Brunswick, Canada; Prof Andreas Kortenkamp, Brunel University, UK; Prof Niels E Skakkebaek, University Dept of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark; Prof Jorma Toppari, University of Turku, Finland; and, Prof R Thomas Zoeller, University of Massachusetts, USA.

The 2013 Berlaymont Declaration on Endocrine Disrupters signatories

Originally posted on 27 May 2013

About HEAL

The Health and Environment Alliance (HEAL) is a leading European not-for-profit organisation addressing how the environment affects health in the European Union (EU). We demonstrate how policy changes can help protect health and enhance people’s quality of life. Read more »


HEAL has over 70 member organisations, representing health professionals, not-for-profit health insurers, doctors, nurses, cancer and asthma groups, citizens, women’s groups, youth groups, environmental NGOs, scientists and public health institutes. Members include international and Europe-wide organisations, as well as national and local groups. Read more »

Contact us

Health and Environment Alliance (HEAL)
28 Boulevard Charlemagne
B1000 Brussels, Belgium
Phone: +32 2 234 3640
Fax: +32 2 234 3649
Press: Elke Zander

Direct telephone numbers: HEAL team page.

HEAL website privacy policy